Showing results (181-190 of 226) with videos related to

Sort By:
Pageof 23
Scientific Reports|June 15, 2022
Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19Joseph P Dewulf, Manon Martin, Sandrine Marie, et al.
Shock (Augusta, Ga.)|July 13, 2013
S100A12 and soluble receptor for advanced glycation end products levels during human severe sepsisAhmed Achouiti, Dirk Föll, Thomas Vogl, et al.
Critical Care Medicine|October 10, 2017
Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma ConcentrationNuala J Meyer, John P Reilly, Brian J Anderson, et al.
Annals of Intensive Care|July 23, 2016
Aerosol delivery with two ventilation modes during mechanical ventilation: a randomized studyJonathan Dugernier, Gregory Reychler, Xavier Wittebole, et al.
Shock (Augusta, Ga.)|March 15, 2016
PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSISSteven M Opal, James L Ellis, Vipin Suri, et al.
Shock (Augusta, Ga.)|December 1, 2005
The activity of pathway-selective estrogen receptor ligands in experimental septic shockSteven M Opal, John E Palardy, Patricia Cristofaro, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plagueHenry S Heine, Arnold Louie, Jeffrey J Adamovicz, et al.
Critical Care Medicine|December 17, 2013
Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study*Gordon R Bernard, Bruno Francois, Jean-Paul Mira, et al.
Critical Care (London, England)|February 26, 2021
Temporal changes in the epidemiology, management, and outcome from acute respiratory distress syndrome in European intensive care units: a comparison of two large cohortsYasser Sakr, Bruno François, Jordi Solé-Violan, et al.
Critical Care Medicine|September 29, 2007
Systemic and local high mobility group box 1 concentrations during severe infectionMarieke A D van Zoelen, Pierre-François Laterre, Suzanne Q van Veen, et al.
Pageof 23